Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement

被引：0

作者：

Luca Faconti ^{[1
]}

Jacob George ^{[2
]}

Sarah Partridge ^{[3
]}

Carmen Maniero ^{[4
]}

Abilash Sathyanarayanan ^{[5
]}

Spoorthy Kulkarni ^{[6
]}

Vikas Kapil ^{[4
]}

Alfredo Petrosino ^{[7
]}

Philip Lewis ^{[8
]}

Terry McCormack ^{[9
]}

Neil R. Poulter ^{[10
]}

Anthony Heagerty ^{[11
]}

Ian B. Wilkinson ^{[12
]}

机构：

[1] St. Thomas’ Hospital,Department of Clinical Pharmacology, King’s College London British Heart Foundation Centre

[2] University of Dundee,Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School

[3] University of Sussex,Department of Primary Care and Public Health, Brighton and Sussex Medical School

[4] Queen Mary University of London,William Harvey Research Institute, Barts & The London School of Medicine & Dentistry

[5] Nottingham University Hospitals,Division of Experimental Medicine, University of Cambridge

[6] Addenbrooke’s Hospital,Barts Blood Pressure Centre of Excellence, Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust

[7] West Smithfield,London Tubular Centre, Department of Renal Medicine, University College London

[8] Royal Free Hospital,Institute of Clinical and Applied Health Research

[9] Stockport NHS Foundation Trust,Imperial Clinical Trials Unit, School of Public Health

[10] Hull York Medical School,Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health

[11] Imperial College London,undefined

[12] University of Manchester,undefined

来源：

Journal of Human Hypertension | 2025年 / 39卷 / 1期

关键词：

D O I：

10.1038/s41371-024-00983-6

中图分类号：

学科分类号：

摘要：

People living with resistant hypertension (RH) are at high risk of adverse cardiovascular events. The British and Irish Hypertension Society has identified suspected RH as a condition for which specialist guidance may improve rates of blood pressure control and help clinicians identify those individuals who may benefit from specialist review. In this position statement we provide a practical approach for the investigation and management of adults with RH. We highlight gaps in the current evidence and identify important future research questions. Our aim is to support the delivery of high-quality and consistent care to people living with RH across the UK and Ireland.

引用

页码：1 / 14

页数：13

共 50 条

[41] Renal Denervation Therapy for the Treatment of Resistant Hypertension: A Position Statement by the Canadian Hypertension Education Program
Khan, Nadia A.
Herman, Robert J.
Quinn, Robert R.
Rabkin, Simon W.
Ravani, Pietro
Tobe, Sheldon W.
Feldman, Ross D.
Wijeysundera, Harindra C.
Padwal, Raj S.
CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (01) : 16 - 21
[42] Society of Behavioral Medicine position statement: Support the updated hypertension guidelines and modify Medicare Part B to improve hypertension management
Kang, Augustine W.
Freedland, Kenneth E.
Janke, Amy
Sumner, Jennifer A.
Hayman, Laura L.
Fitzgibbon, Marian
Buscemi, Joanna
Dulin, Akilah
TRANSLATIONAL BEHAVIORAL MEDICINE, 2020, 10 (02) : 495 - 497
[43] Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society
Chattranukulchai, Pairoj
Roubsanthisuk, Weranuj
Kunanon, Sirisawat
Kotruchin, Praew
Satirapoj, Bancha
Wongpraparut, Nattawut
Sunthornyothin, Sarat
Sukonthasarn, Apichard
HYPERTENSION RESEARCH, 2024, : 2447 - 2455
[44] Current practice for the assessment and management of non-adherence in patients with resistant hypertension: survey of British Hypertension Society members
Hameed, Mohammed
Cappuccio, Franco
Padmanabhan, Sandosh
Dasgupta, Indranil
JOURNAL OF HUMAN HYPERTENSION, 2016, 30 (10) : 635 - 635
[45] Correction: The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension Society
Francesco P. Cappuccio
Peter S. Sever
Journal of Human Hypertension, 2020, 34 : 338 - 338
[46] Spanish Society of Hypertension position statement on the 2017 ACC/AHAhypertension guidelines
Gijon-Conde, T.
Gorostidi, M.
Camafort, M.
Abad-Cardiel, M.
Martin-Rioboo, E.
Morales-Olivas, F.
Vinyoles, E.
Armario, P.
Banegas, J. R.
Coca, A.
de la Sierra, A.
Martell-Claros, N.
Redon, J.
Ruilope, L. M.
Segura, J.
HIPERTENSION Y RIESGO VASCULAR, 2018, 35 (03): : 119 - 129
[47] DIABETES AND HYPERTENSION - AUSTRALIAN-DIABETES-SOCIETY POSITION-STATEMENT
GILBERT, RE
JASIK, M
DELUISE, M
OCALLAGHAN, CJ
COOPER, ME
MEDICAL JOURNAL OF AUSTRALIA, 1995, 163 (07) : 372 - 375
[48] Diabetes and hypertension. Australian Diabetes Society position statement - Reply
Gilbert, R
Cooper, ME
MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (09) : 572 - 572
[49] Guidelines for management of hypertension: report of the third working party of the British Hypertension Society
Ramsay, LE
Williams, B
Johnston, GD
MacGregor, GA
Poston, L
Potter, JF
Poulter, NR
Russell, G
JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (09) : 569 - 592
[50] Guidelines for management of hypertension: report of the third working party of the British Hypertension Society
LE Ramsay
B Williams
GD Johnston
GA MacGregor
L Poston
JF Potter
NR Poulter
G Russell
Journal of Human Hypertension, 1999, 13 : 569 - 592

← 1 2 3 4 5 →